Biomarin Provides Hemophilia A Clinical Development Program Updates

BioMarin recently shared a community update on their Hemophilia A Clinical Development Program for valoctocogene roxaparvovec, the company’s investigational gene therapy currently under review by the U.S. Food and Drug Administration (FDA). It included a brief...

National Hemophilia Foundation Set to Celebrate 75 Years in 2023

Organization set to look back while moving ahead during historic year NEW YORK — In 2023, the National Hemophilia Foundation (NHF) reaches its jubilee year with a special 75th anniversary celebration. To note this historic milestone, NHF is launching a year-long...

WNYBC & UB Partnership

Western New York BloodCare is proud to be included in the University at Buffalo’s circle of visionaries. Our growing partnership with UB has been in the works and is finally coming to fruition with programs that allow students a deeper understanding of our patient...

Accumulator Bill (S.5299-A) Passed Senate Unanimously!

Many thanks to Majority Leader Andrea Stewart-Cousins, Senator Gustavo Rivera, and the entire NY Senate for passing S.5299-A to help New Yorkers afford their medications and ensure that #AllCopaysCount!  

Albany Days 2022 Newsletter

Interprofessional Education Leadership Team Receives National Award

Experts in their field, the UB Interprofessional Educators received a national award from the National Academies of Practice for their work in interprofessional practice and education. Western New York BloodCare is honored to be working with such a talented team! Read...